Old Web
English
Sign In
Acemap
>
authorDetail
>
Tatiana Knox
Tatiana Knox
Brigham and Women's Hospital
BET inhibitor
Biology
Molecular biology
Bromodomain
BRD4
3
Papers
31
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Combined targeting of the BRD4-NUT-p300 axis in NUT midline carcinoma by dual selective bromodomain inhibitor, NEO2734.
2020
Molecular Cancer Therapeutics
Chevaun D Morrison-Smith
Tatiana Knox
Ivona Filic
Kara M Soroko
Benjamin K. Eschle
Margaret K. Wilkens
Prafulla C. Gokhale
Francis J. Giles
Andrew Griffin
bill brown
Geoffrey I. Shapiro
Beth E. Zucconi
Philip A. Cole
Madeleine E. Lemieux
Christopher A. French
Show All
Source
Cite
Save
Citations (20)
Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma
2020
Oncogene
Xin Zhang
Tim Zegar
Anais Lucas
Chevaun D Morrison-Smith
Tatiana Knox
Christopher A. French
Stefan Knapp
Susanne Müller
Jens T. Siveke
Show All
Source
Cite
Save
Citations (11)
Abstract B014: Novel dual BET/p300 bromodomain inhibitors therapeutically inhibit BRD4-NUT driven NUT Carcinomas
2019
Molecular Cancer Therapeutics
Chevaun D Morrison-Smith
Amy DiBona
Erica M. Walsh
Kristina Danga
Ivona Filic
Tatiana Knox
Adlai R. Grayson
Michael J. Cameron
Christopher A. French
Show All
Source
Cite
Save
Citations (0)
1